<p>SURMOUNT 1 Trial. The aim of this trial was to investigate the safety and efficacy of Tirzepatide, a novel GLP + GIP in people with obesity. We discuss the trial in this episode. </p>

SURMOUNT 1 Trial. The aim of this trial was to investigate the safety and efficacy of Tirzepatide, a novel GLP + GIP in people with obesity. We discuss the trial in this episode.

95. Tirzepatide Once Weekly for the Treatment of Obesity

Become a Paid Subscriber: <a href="https://podcasters.spotify.com/pod/show/michael-salzle/subscribe" target="_blank">https://podcasters.spotify.com/pod/show/michael-salzle/subscribe</a>

Healthspan. The podcast that will add years to your life, and life to your years

Health & Fitness

Fitness

Become a Paid Subscriber: https://podcasters.spotify.com/pod/show/michael-salzle/subscribe Healthspan. The podcast that will add years to your life, and life to your years

Become a Paid Subscriber: <a href="https://podcasters.spotify.com/pod/show/michael-salzle/subscribe" rel="noopener noreferrer">https://podcasters.spotify.com/pod/show/michael-salzle/subscribe</a>

Healthspan. The podcast that will add years to your life, and life to your years

Share 95. Tirzepatide Once Weekly for the Treatment of Obesity

Sign up to save your podcasts

95. Tirzepatide Once Weekly for the Treatment of Obesity

95. Tirzepatide Once Weekly for the Treatment of Obesity